Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Haller, G W ^a   Bechstein, W O ^a   Neuhaus, R ^a   Raakow, R ^a   Berg, T ^a   Hopf, U ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Famciclovir; Hepatitis B; Liver transplantation

Indexed keywords

FAMCICLOVIR; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG TOLERABILITY; GRAFT FAILURE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REINFECTION;

EID: 0029903986     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01611.x     Document Type: Article

References (9)

1. Neuhaus P, Steffen R, Blumhardt G, Bechstein WO, Keck H, Lemmens HP, Neuhaus R, Lobeck H, König V, Hopf U (1991) Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAg positive patients. Transplant Proc 23: 1522-1524
2. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, Bismuth H (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329: 1842-1847
3. Freeman RB, Sanchez H, Lewis WD, Sherburne B, Dzik WH, Khettry U, Hing S, Zeldis JB, Jenkins RL (1991) Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation 51: 793-797
4. Lucey MR, Graham DM, Martin P, Di Bisceglie A, Rosenthal S, Waggoner JG, Merion RM, Campbell DA, Nostrant TT, Appelman HD (1992) Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 33: 1390-1396
5. Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, Lautz H-U, Böker K, Stangel W, Pichlmayr R (1991) Liver transplantation in HBs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 13: 90-96
6. Vere Hodge RA, Sutton D, Boyd MR, Harnden MR, Jarvest RL (1989) Selection of an oral prodrug (BRL 42810; famciclovir) for the anti-herpes virus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine;penciclovir]. Antimicrob Agents Chemother 33: 1765-1773
7. Korba BE, Milman G (1991) A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res 15: 217-228
8. Tsiquaye KN, Slomka MJ, Maung M (1994) Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in vivo. J Med Virol 42: 306-310
9. Böcker KHW, Ringe B, Krüger M, Pichlmayr R, Manns MP (1995) Prostaglandin E plus famciclovir - a new con-cept for treatment of severe hepatitis B after liver transplantation. Transplantation 57: 1706-1708